Trinity Biotech ROE 2010-2024 | TRIB
Current and historical return on equity (ROE) values for Trinity Biotech (TRIB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Trinity Biotech ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-06-30 | $-0.02B | $-0.03B | 98.92% |
| 2024-03-31 | $-0.02B | $-0.02B | 117.33% |
| 2023-12-31 | $-0.03B | $-0.02B | 169.49% |
| 2023-09-30 | $-0.03B | $-0.02B | 313.51% |
| 2023-06-30 | $-0.03B | $-0.01B | 953.85% |
| 2023-03-31 | $-0.04B | $-0.01B | -1000.00% |
| 2022-12-31 | $-0.04B | $-0.00B | -1093.33% |
| 2022-09-30 | $-0.03B | $0.01B | -752.94% |
| 2022-06-30 | $-0.02B | $0.02B | -800.00% |
| 2022-03-31 | $-0.01B | $-0.01B | 1040.00% |
| 2021-12-31 | $0.00B | $0.00B | 400.00% |
| 2021-09-30 | $-0.01B | $0.00B | 3200.00% |
| 2021-06-30 | $-0.00B | $0.00B | -160.00% |
| 2021-03-31 | $-0.00B | $0.00B | -200.00% |
| 2020-12-31 | $-0.01B | $-0.00B | -480.00% |
| 2020-09-30 | $-0.02B | $0.01B | -633.33% |
| 2020-06-30 | $-0.03B | $-0.00B | -236.36% |
| 2020-03-31 | $-0.03B | $0.00B | -142.86% |
| 2019-12-31 | $-0.03B | $0.01B | -88.19% |
| 2019-09-30 | $-0.03B | $0.04B | -69.88% |
| 2019-06-30 | $-0.03B | $0.04B | -57.44% |
| 2019-03-31 | $-0.02B | $0.04B | -39.46% |
| 2018-12-31 | $-0.02B | $0.04B | -35.92% |
| 2018-09-30 | $-0.04B | $0.07B | -61.65% |
| 2018-06-30 | $-0.04B | $0.07B | -55.26% |
| 2018-03-31 | $-0.04B | $0.07B | -48.84% |
| 2017-12-31 | $-0.04B | $0.07B | -42.38% |
| 2017-09-30 | $-0.10B | $0.11B | -91.88% |
| 2017-06-30 | $-0.10B | $0.11B | -74.77% |
| 2017-03-31 | $-0.10B | $0.11B | -61.97% |
| 2016-12-31 | $-0.10B | $0.11B | -54.45% |
| 2016-09-30 | $0.00B | $0.21B | 1.42% |
| 2016-06-30 | $0.02B | $0.21B | 7.55% |
| 2016-03-31 | $0.02B | $0.21B | 8.08% |
| 2015-12-31 | $0.02B | $0.21B | 10.59% |
| 2015-09-30 | $0.02B | $0.21B | 11.30% |
| 2015-06-30 | $0.02B | $0.21B | 7.52% |
| 2015-03-31 | $0.02B | $0.20B | 8.11% |
| 2014-12-31 | $0.02B | $0.20B | 8.24% |
| 2014-09-30 | $0.02B | $0.20B | 8.91% |
| 2014-06-30 | $0.01B | $0.20B | 5.38% |
| 2014-03-31 | $0.01B | $0.19B | 5.54% |
| 2013-12-31 | $0.01B | $0.18B | 5.65% |
| 2013-09-30 | $0.01B | $0.18B | 5.19% |
| 2013-06-30 | $0.02B | $0.18B | 9.36% |
| 2013-03-31 | $0.02B | $0.18B | 9.57% |
| 2012-12-31 | $0.02B | $0.17B | 9.80% |
| 2012-09-30 | $0.02B | $0.17B | 10.08% |
| 2012-06-30 | $0.02B | $0.16B | 10.34% |
| 2012-03-31 | $0.02B | $0.16B | 10.56% |
| 2011-12-31 | $0.02B | $0.15B | 10.81% |
| 2011-09-30 | $0.02B | $0.15B | 11.00% |
| 2011-06-30 | $0.02B | $0.15B | 10.53% |
| 2011-03-31 | $0.06B | $0.15B | 44.60% |
| 2010-12-31 | $0.06B | $0.14B | 49.49% |
| 2010-09-30 | $0.06B | $0.14B | 55.68% |
| 2010-06-30 | $0.06B | $0.13B | 64.86% |
| 2010-03-31 | $0.01B | $0.08B | 15.53% |
| 2009-12-31 | $0.01B | $0.08B | 16.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.008B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
| Stryker (SYK) | United States | $137.290B | 32.08 |
| Boston Scientific (BSX) | United States | $122.743B | 37.38 |
| Medtronic (MDT) | Ireland | $114.552B | 17.05 |
| EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
| ResMed (RMD) | United States | $35.117B | 30.92 |
| Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
| Terumo (TRUMY) | Japan | $28.517B | 40.27 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
| Baxter (BAX) | United States | $19.851B | 13.46 |
| Insulet (PODD) | United States | $16.269B | 68.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.247B | 30.63 |
| Demant (WILYY) | Denmark | $8.667B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
| Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
| ICU Medical (ICUI) | United States | $4.261B | 40.67 |
| Haemonetics (HAE) | United States | $4.084B | 20.20 |
| TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
| Neogen (NEOG) | United States | $3.599B | 37.75 |
| Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
| GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
| Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
| Envista Holdings (NVST) | United States | $3.398B | 18.13 |
| QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
| Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
| Warby Parker (WRBY) | United States | $1.614B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
| InMode (INMD) | Israel | $1.464B | 9.32 |
| AtriCure (ATRC) | United States | $1.372B | 0.00 |
| Owens & Minor (OMI) | United States | $1.247B | 9.63 |
| Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
| Evolus (EOLS) | United States | $1.006B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
| National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 116.64 |
| Quanterix (QTRX) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
| Jin Medical (ZJYL) | China | $0.439B | 0.00 |
| ZimVie (ZIMV) | United States | $0.435B | 40.41 |
| Valneva SE (VALN) | France | $0.432B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
| Cerus (CERS) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
| Aurora Cannabis (ACB) | Canada | $0.319B | 0.00 |
| Biote (BTMD) | United States | $0.307B | 14.18 |
| Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Zynex (ZYXI) | United States | $0.257B | 45.00 |
| Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.163B | 67.33 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
| Brainsway (BWAY) | Israel | $0.135B | 161.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
| Veru (VERU) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 11.44 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
| InterCure (INCR) | Israel | $0.087B | 14.62 |
| Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Exagen (XGN) | United States | $0.055B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 21.30 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |